Literature DB >> 14991903

Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.

Thomas Pufe1, Viola Harde, Wolf Petersen, Mary B Goldring, Bernhard Tillmann, Rolf Mentlein.   

Abstract

VEGF (vascular endothelial growth factor), an important angiogenesis factor, appears also to be involved in inflammatory processes. Recent studies have shown that VEGF and its receptors (VEGFR) are expressed on osteoarthritic, but not on normal adult, chondrocytes. To elucidate possible functions of VEGF in osteoarthritic cartilage, the effects of VEGF were studied on immortalized human chondrocytes. Activated matrix metalloproteinase (MMP)-1, MMP-3, MMP-13, tissue inhibitor of metalloproteinases (TIMP)-1, TIMP-2, interleukin (IL)-1beta, IL-6, and tumour necrosis factor-alpha (TNF-alpha) were measured in culture supernatants by enzyme-linked immunosorbent assays, nitric oxide with the Griess reagent, and cell proliferation by [3H]thymidine incorporation. VEGFR-2 mRNA was quantified by real-time reverse transcription-polymerase chain reaction and the protein was identified by immuno-gold electron microscopy. Intracellular signal transduction effects were determined by western blots and electrophoretic mobility shift assays. The chondrocyte cell lines C28/I2, C20/A4, and T/C28a2/a4 expressed functionally active VEGFR-2. VEGF stimulation induced receptor phosphorylation, activation of the mitogen-activated protein kinases ERK 1/2, and long-lasting activation of the transcription factor AP-1 (activator protein-1). VEGF increased secreted MMP-1, MMP-3, and especially MMP-13, which could be effectively reduced by an inhibitor of VEGFR-2 kinase activity. Interestingly, VEGF diminished the expression of TIMP-1 and especially TIMP-2. Under hypoxic conditions, as occur in cartilage, the reduction in TIMP levels was even greater. Furthermore, VEGF induced IL-1beta, IL-6, TNF-alpha, and nitric oxide expression to a small extent and stimulated the proliferation of immortalized chondrocytes. These findings indicate that VEGF is an autocrine stimulator of immortalized chondrocytes that mediates mainly destructive processes in osteoarthritis. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991903     DOI: 10.1002/path.1527

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  50 in total

1.  Moderate joint loading reduces degenerative actions of matrix metalloproteinases in the articular cartilage of mouse ulnae.

Authors:  Hui B Sun; Liming Zhao; Shigeo Tanaka; Hiroki Yokota
Journal:  Connect Tissue Res       Date:  2011-12-07       Impact factor: 3.417

Review 2.  Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.

Authors:  A W Eckert; M Kappler; J Schubert; H Taubert
Journal:  Oral Maxillofac Surg       Date:  2012-05-17

3.  Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.

Authors:  Xufang Zhang; Ross Crawford; Yin Xiao
Journal:  J Mol Med (Berl)       Date:  2016-05-10       Impact factor: 4.599

4.  Manipulation of the HIF-Vegf pathway rescues methyl tert-butyl ether (MTBE)-induced vascular lesions.

Authors:  Josephine A Bonventre; Tiffany S Kung; Lori A White; Keith R Cooper
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-12       Impact factor: 4.219

Review 5.  Anti-inflammatory strategies in cartilage repair.

Authors:  Ying Zhang; Tyler Pizzute; Ming Pei
Journal:  Tissue Eng Part B Rev       Date:  2014-06-23       Impact factor: 6.389

Review 6.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

7.  Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines.

Authors:  Basam Z Barkho; Ari E Munoz; Xuekun Li; Lu Li; Lee Anna Cunningham; Xinyu Zhao
Journal:  Stem Cells       Date:  2008-09-25       Impact factor: 6.277

8.  Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.

Authors:  Deike Varoga; Wolf Drescher; Melanie Pufe; Godo Groth; Thomas Pufe
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

9.  Tailoring adipose stem cell trophic factor production with differentiation medium components to regenerate chondral defects.

Authors:  Christopher S D Lee; Elyse Watkins; Olivia A Burnsed; Zvi Schwartz; Barbara D Boyan
Journal:  Tissue Eng Part A       Date:  2013-03-28       Impact factor: 3.845

10.  Osteochondral angiogenesis and increased protease inhibitor expression in OA.

Authors:  R E Fransès; D F McWilliams; P I Mapp; D A Walsh
Journal:  Osteoarthritis Cartilage       Date:  2009-12-21       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.